Previous Article | Next Article 
Journal of Virology, May 2000, p. 4898-4901, Vol. 74, No. 10
0022-538X/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
L* Protein of Theiler's Murine Encephalomyelitis
Virus Is Required for Virus Growth in a Murine Macrophage-Like
Cell Line
Masatsugu
Obuchi,1
Jiro
Yamamoto,2
Takato
Odagiri,1
Mohammed Nasir
Uddin,1
Hideaki
Iizuka,2 and
Yoshiro
Ohara1,*
Departments of
Microbiology1 and
Neurosurgery,2 Kanazawa Medical
University, Uchinada, Ishikawa 920-0293, Japan
Received 28 July 1999/Accepted 14 February 2000
 |
ABSTRACT |
We sought to confirm the importance of L* protein for growth of
Theiler's murine encephalomyelitis virus (TMEV) in a
macrophage-like cell line, J774-1. The protein is out of frame with the
polyprotein and synthesized in DA but not GDVII subgroup strains of
TMEV. A recombinant virus, DANCL*/GD, which substitutes the DA 5'
noncoding and L* coding regions for the corresponding regions of GDVII
and synthesizes L* protein, grew with little restriction in J774-1 cells. In contrast, another recombinant virus, DANCL*-1/GD, which has
an ACG rather than an AUG as the starting codon of L* protein at
nucleotide 1079, resulting in no synthesis of L* protein, did not grow
well. No significant difference between the rates of adsorption to
J774-1 cells of these viruses was observed. RNase protection assay
demonstrated that DANCL*/GD viral RNA significantly increased, whereas
only a minimal increase was observed for DANCL*-1/GD. The present study
suggests that L* protein is required for virus growth in macrophages.
 |
TEXT |
Strains of Theiler's murine
encephalomyelitis virus (TMEV), a member of the genus
Cardiovirus of the family Picornaviridae, are
divided into two subgroups on the basis of their different in vivo
activities (13, 16, 18). GDVII subgroup strains cause acute
polioencephalomyelitis in mice, with neither virus persistence nor
demyelination. In contrast, the DA or TO subgroup strain induces an
early nonfatal polioencephalomyelitis in weanling mice, followed by
chronic demyelination with virus persistence. In vitro biological
differences between the two subgroups are also reported; they include
the size of plaques (10) and the crystalline arrays of the
GDVII subgroup versus the membranous structures of the DA subgroup in
infected BHK-21 cells (5). Recently, members of our group
reported another in vitro biological activity distinguishing the two
subgroups, i.e., virus growth in a murine macrophage cell line, J774-1
(15). The DA strain replicates in J774-1 cells, while the
GDVII strain does not. This observation is of interest because
macrophages are a major site of viral persistence, which is essential
for demyelination (2, 11). Additional studies suggested that
a 17-kDa viral protein, called L* protein, is responsible for virus
growth in J774-1 cells (25).
L* protein is translated out of frame with the polyprotein from an
alternative AUG, 13 nucleotides (nt) downstream from the authentic
polyprotein AUG (8). L* protein is only synthesized in DA
subgroup strains, since the L* AUG is present in DA but not in GDVII
subgroup strains (14). A role for L* protein in TMEV-induced
demyelination has been studied in loss-of-function experiments using
DAL*-1 mutant virus (3, 7, 9, 25), which has a mutation of
the AUG to ACG at nt 1079 in the background of a DA strain and,
therefore, does not synthesize L* protein. In this study, we
constructed chimeric viruses in which L* protein is synthesized in the
background of the parental GDVII strain, in order to further explore
the function of L* protein in virus growth in J774-1 cells.
A series of parental and chimeric cDNAs are shown in Fig.
1. pDAFL3 and pGDVIIFL2 are full-length
infectious cDNA clones generated from DA and GDVII strains of TMEV,
respectively (6, 23). pDAL*-1 is a mutant construct in which
the only difference from pDAFL3 is a change of the AUG at nt 1079 to
ACG (8). In order to be able to transfer the entire DA L*
coding region to GDVII, the KpnI(nt 935)-NcoI(nt
1962) fragments of pDAFL3, pDAL*-1, and pGDVIIFL2 were subcloned
separately and then an NheI site was introduced at nt 1545 by site-directed mutagenesis. pDANCL*/GD was constructed by the
replacement of a pDAFL3 fragment (nt 1 to 1549) with the corresponding
fragment of pGDVIIFL2. pDANCL*-1/GD was constructed by the replacement
of nt 1 to 1549 pDAL*-1 fragment with the corresponding fragment of
pGDVIIFL2.

View larger version (14K):
[in this window]
[in a new window]
|
FIG. 1.
Parental and recombinant cDNAs generated to delineate
the role of L* protein for virus growth in J774-1 cells. The positions
of the TMEV noncoding and coding areas are shown at the top. The DA
genome and segments from it are shown as open bars, and the GDVII
genome is shown as closed bars. The stars indicate point mutations of U
to C in the L* starting codon at nt 1080. NheI indicates an
NheI site introduced at the nt 1547 L* stop codon.
|
|
At first, to confirm the synthesis of L* protein in recombinant viruses
in vivo, we radiolabeled BHK-21 cells infected with those recombinants.
Radiolabeling of BHK-21 cells, which are permissive for TMEV and
maintained in Eagle's minimum essential medium supplemented with 5%
calf serum and 60 µg of kanamycin per ml, was performed as previously
described (7). A quantity of 106 cells in a
35-mm-diameter plastic culture dish were mock infected or infected with
parental and recombinant viruses at a multiplicity of infection (MOI)
of 10 PFU per cell. After adsorption at 37°C for 1 h, the cells
were incubated in culture medium containing 2% calf serum and
actinomycin D (2.4 µg/ml). After 9 h, the medium was replaced
with methionine-free Eagle's minimum essential medium containing 1%
calf serum and incubated for another 1 h. A total of 50 µCi of
L-[35S]methionine was then added. After
12 h, the labeled cells were scraped, washed twice with cold
phosphate-buffered saline, and dissolved in the sample buffer (50 mM
Tris-HCl [pH 6.8], 2% sodium dodecyl sulfate [SDS], 0.005%
bromophenol blue, 10% glycerol, and 6%
-mercaptoethanol).
Radiolabeled proteins were separated by SDS-15% polyacrylamide gel
electrophoresis (PAGE) and analyzed by autoradiography. As shown in
Fig. 2A, lanes 1 and 3, respectively, the
parental DA and DANCL*/GD viruses, both of which have an L* coding
sequence, produced a significant amount of 17-kDa protein. It was
confirmed that the recombinant DANCL*/GD could produce almost the same
amount of 17-kDa protein as the parental DA virus. On the other hand,
as expected, no 17-kDa protein was detected following infection with
the parental GDVII virus or the DANCL*-1/GD virus (Fig. 2A, lanes 2 and
4), since both viruses have an ACG rather than an AUG starting codon at
nt 1079. In order to confirm whether the 17-kDa protein is L*, Western
blotting was performed with a rabbit polyclonal antibody to synthetic
peptides corresponding to L* protein amino acid residues 70 to 88 (NPRETPLHLTRVTPSPQVT). The peptides were synthesized and coupled to
keyhole limpet hemocyanin by Sawady Technology Co., Inc. (Tokyo,
Japan); the peptides were 92.4% pure as determined by high-pressure
liquid chromatography. Unlabeled proteins were separated by SDS-15%
PAGE and transferred to a nitrocellulose membrane (Amersham Pharmacia
Biotech, Ltd., Little Chalfont, Buckinghamshire, United Kingdom).
Horseradish peroxidase-linked anti-rabbit immunoglobulin G (Amersham
Pharmacia Biotech, Ltd.) as the second antibody was detected by
enhanced chemiluminescence reagents (Amersham Pharmacia Biotech, Ltd.). As shown in Fig. 2B, lanes 1 and 3, respectively, a 17-kDa band was
bound to the anti-L* antibody in DA- and DANCL*/GD-infected cells.

View larger version (29K):
[in this window]
[in a new window]
|
FIG. 2.
L* protein synthesis of the parental and the recombinant
viruses. (A) BHK-21 cells infected with virus at an MOI of 10 PFU per
cell were radiolabeled with L-[35S]methionine
as described in the text. Synthesized proteins were analyzed by
SDS-15% PAGE. (B) Electrophoresed proteins were analyzed by Western
blotting with a rabbit polyclonal antibody to a synthetic peptide and
horseradish peroxidase-linked anti-rabbit immunoglobulin G as the first
and the second antibodies, respectively. In both SDS-PAGE and Western
blotting analyses, a distinct 17-kDa band was clearly demonstrated in
DA- and DANCL*/GD-infected cells, but not in GDVII-, DANCL*-1/GD-, and
mock-infected cells. Lanes: 1, DA-infected cells; 2, GDVII-infected
cells; 3, DANCL*/GD-infected cells; 4, DANCL*-1/GD-infected cells; 5, mock-infected cells. The arrow in panel A indicates a 17-kDa protein.
|
|
Next, the kinetics of growth of the recombinant viruses in BHK-21 and
J774-1 cells was examined as previously described (15, 25).
J774-1, an H-2d macrophage-like cell line
derived from a tumor of a female BALB/c mouse (22), was
obtained from the Cancer Cell Repository, Tohoku University, Sendai,
Japan, and maintained in RPMI 1640 medium supplemented with 10% fetal
bovine serum. In a 35-mm-diameter plastic culture dish, 106
cells were infected at an MOI of 10 PFU per cell with each virus. The
culture supernatants and cell lysates were harvested at the indicated
times (0, 3, 6, 12, and 24 h after infection) and titrated by a
standard plaque assay on BHK-21 cells. As shown in Fig.
3A, in BHK-21 cells, the recombinant
viruses that respectively contained (DANCL*/GD) and lacked
(DANCL*-1/GD) the L* coding sequence showed similar growth kinetics;
the titers of both cell-free and cell-associated viruses reached a peak
of 108 PFU/ml at 12 h postinoculation (p.i.). The
titers then gradually decreased. However, the growth kinetics following
infection of J774-1 cells differed for the two recombinant viruses
(Fig. 3B). In DANCL*/GD infection, the titer peaked at 12 h p.i.,
at a level lower (by a multiple of 1 to 2 log units) than that seen in
BHK-21 cells, and then decreased gradually. The data indicated that
DANCL*/GD, which contains the L* AUG and coding sequence, can grow in
J774-1 cells, although it is somewhat restricted compared to BHK-21
cells. On the other hand, the multiplication of DANCL*-1/GD without the L* AUG was severely restricted. As for DANCL*/GD, the titer reached a
peak at 12 h p.i.; however, the level of virus was overall
significantly lower, being at the most 105 PFU/ml.

View larger version (13K):
[in this window]
[in a new window]
|
FIG. 3.
Kinetics of recombinant DANCL*/GD and DANCL*-1/GD
viruses in BHK-21 (A) and J774-1 (B) cells. The culture supernatants
and cell lysates of infected cells were harvested at the indicated
times and subjected to titer determination by a standard plaque assay
on BHK-21 cells. Data are the means of three independent experiments.
Details of the construction are provided in the text and shown in Fig.
1. , culture supernatant of DANCL*/GD-infected cells; , cell
lysate of DANCL*/GD-infected cells; , culture supernatant of
DANCL*-1/GD-infected cells; , cell lysate of DANCL*-1/GD-infected
cells.
|
|
We next examined which step of the infection cycle restricted
DANCL*-1/GD virus growth. The initial step of infection, i.e., adsorption of virus to J774-1 cells, was studied first. A quantity of
106 cells in a 35-mm-diameter plastic culture dish was
inoculated with each virus at an MOI of 10 PFU per cell. After virus
adsorption at 4°C for 60 min, the supernatants were harvested and
titrated by a standard plaque assay on BHK-21 cells. The rate of viral attachment to cells was calculated by the ratio of cell-attached virus
titer to input virus titer according to the method described in a
previous report (24). Statistical significance of the
difference in the adsorption rates of DANCL*/GD and DANCL*-1/GD viruses
was determined by a two-sample Student's t test. The
adsorption rates of DANCL*/GD and DANCL*-1/GD viruses were 65.0 and
67.1%, respectively (data are means of three independent experiments).
Statistical analysis showed no significant difference in the adsorption
rates of these two viruses (P > 0.05).
Viral RNA synthesis of DANCL*/GD and DANCL*-1/GD viruses was finally
examined by an RNase protection assay with J774-1 cells as previously
described (25). pGDVIIFL2 was used as a template for in
vitro transcription. To prepare an antisense probe, pGDVIIFL2 was
cleaved at the PpuMI (nt 7575) site in the viral genome. The linearized plasmid was transcribed in vitro with T3 RNA polymerase in
the presence of [
-32P]UTP. The radiolabeled
577-nt-long RNA probe contained 526 nt of sequence complementary to the
3' region of the viral genome and 51 nt of vector sequence (6, 19,
20). Total RNA was extracted and purified from 106
virus-infected cells. A 2-µg portion of RNA and 100,000 cpm of [
-32P]UTP-labeled probe were hybridized for 16 h
at 42°C and treated with a mixture of 250 U of RNase A per ml and
10,000 U of RNase T1 (Ambion, Inc., Austin, Tex.) per ml.
The RNase-resistant fragments were detected by electrophoresis on a 5%
polyacrylamide gel containing 8 M urea. The gels were exposed to X-ray
film (Fuji Photo Film Co., Ltd., Kanagawa, Japan). As shown in Fig.
4, a significant amount of DANCL*/GD
viral genomic RNA was detected at 3 h p.i., and it had clearly
increased by 9 h p.i. On the other hand, DANCL*-1/GD viral genomic
RNA was scarcely visible at 3 h p.i., with only a low amount
detectable at 9 h p.i. The results were consistent with the growth
kinetics of the recombinant viruses in J774-1 cells.

View larger version (23K):
[in this window]
[in a new window]
|
FIG. 4.
Genomic RNA synthesis in the recombinant virus-infected
J774-1 cells. Total RNA was extracted from the cells of DANCL*/GD or
DANCL*-1/GD virus at 3 and 9 h p.i. A 2-µg quantity of RNA was
hybridized with [ -32P]UTP-labeled riboprobe and
treated with RNase solution as described in the text. The
RNase-resistant fragments were denatured and electrophoresed on a 5%
polyacrylamide-8 M urea gel. Lanes P and 1, [ -32P]UTP-labeled probe and mock-infected J774-1
cells, respectively; lanes 2 and 3, J774-1 cells infected with
DANCL*/GD at 3 and 9 h p.i., respectively; lanes 4 and 5, J774-1
cells infected with DANCL*-1/GD at 3 and 9 h p.i., respectively.
|
|
One of our goals is to delineate molecular determinants for TMEV growth
in macrophages, which are a major site of virus persistence (4,
12). Our previous data suggested that L* protein, which is
synthesized out of frame with the polyprotein from an alternative initiation codon in the L coding region of DA subgroup strains, is a
key determinant of the cell type-specific restriction of virus growth
(17). The previous study made use of a DA mutant virus which
failed to synthesize L* protein. In the present study, in order to
further confirm a role for the L* protein, we used a GDVII recombinant
virus that contains the L* AUG and coding sequence. We substituted the
L* coding region into GDVII, since the amino acid sequence homology of
this region is only 79% for DA and GDVII strains (19, 21).
By comparing the activities of DANCL*/GD virus with DANCL*-1/GD virus,
we confirmed the importance of the L* protein for virus growth in
J774-1 cells, which importance was previously supported by studies with
DAL*-1 mutant virus (25); DANCL*/GD with L* protein grew
well in J774-1 cells, while DANCL*-1/GD without L* protein did not.
Although 19% of the DA sequence (nt 1 to 1549) was substituted into
GDVII to generate the recombinant viruses, the only difference between
DANCL*/GD and DANCL*-1/GD in the chimeric segment was a U versus C at
nt 1080. In addition, an RNase protection assay demonstrated the
difference in the amount of viral genomic RNA between the two
recombinant viruses. It remains to be elucidated which step regulates
virus growth in J774-1 cells, i.e., polyprotein translation,
polyprotein processing, or viral RNA replication.
The present investigation demonstrated that the two recombinant viruses
showed similar growth kinetics in BHK-21 cells but different growth
kinetics in J774-1 cells. This suggests that L* protein-dependent virus
growth is host cell restricted. Our data also demonstrated that DA but
not GDVII strains grow in particular monocyte or macrophage lineage
cell lines but that both strain types grow equally in other neural and
nonneural cell lines (17). The ability of DA to grow in
macrophages is important for the maintenance of viral genome, which is
one of the factors influencing the establishment of virus persistence
(1). Therefore, the L* protein-dependent virus growth may be
important in regulating DA-induced demyelination. The host cell
restriction suggests that some host factor(s) interacts with the L*
protein in influencing virus growth in macrophages. A clarification of
the host factor and the mechanisms that underlie L* protein-dependent
virus growth may lead to a better understanding of the basis for virus
persistence in this system as well as in other viruses.
 |
ACKNOWLEDGMENTS |
This work was supported by a Grant-in-Aid for Scientific Research
from the Ministry of Education, Science, Sports and Culture; a grant
from the Japan Health Sciences Foundation; a grant for Project Research
from Kanazawa Medical University (P99-7); and a grant for the Science
Research Promotion Fund (1999) from the Promotion and Mutual Aid
Corporation for Private Schools of Japan.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Department of
Microbiology, Kanazawa Medical University, Uchinada, Ishikawa 920-0293, Japan. Phone: 81-76-286-2211, ext. 3011. Fax: 81-76-286-3961. E-mail:
ohara{at}kanazawa-med.ac.jp.
 |
REFERENCES |
| 1.
|
Ahmed, R.,
L. A. Morrison, and D. M. Knipe.
1996.
Persistence of viruses, p. 219-249.
In
B. N. Fields, D. M. Knipe, P. M. Howley, R. M. Chanock, J. L. Melnick, T. P. Monath, B. Roizman, and S. E. Straus (ed.), Fields virology, 3rd ed., vol. 1. Lippincott-Raven, Philadelphia, Pa.
|
| 2.
|
Chamorro, M.,
C. Aubert, and M. Brahic.
1986.
Demyelinating lesions due to Theiler's virus are associated with ongoing central nervous system infection.
J. Virol.
57:992-997[Abstract/Free Full Text].
|
| 3.
|
Chen, H.-H.,
W.-P. Kong,
L. Zhang,
P. L. Ward, and R. P. Roos.
1995.
A picornaviral protein synthesized out of frame with the polyprotein plays a key role in a virus-induced immune-mediated demyelinating disease.
Nat. Med.
1:927-931[CrossRef][Medline].
|
| 4.
|
Clatch, R. J.,
S. D. Miller,
R. Metzner,
M. C. Dal Canto, and H. L. Lipton.
1990.
Monocytes/macrophages isolated from the mouse central nervous system contain infectious Theiler's murine encephalomyelitis virus (TMEV).
Virology
176:244-254[CrossRef][Medline].
|
| 5.
|
Friedmann, A., and H. L. Lipton.
1980.
Replication of Theiler's murine encephalomyelitis viruses in BHK21 cells: an electron microscopic study.
Virology
101:389-398[CrossRef][Medline].
|
| 6.
|
Fu, J.,
S. Stein,
L. Rosenstein,
T. Bodwell,
M. Routbort,
B. L. Semler, and R. P. Roos.
1990.
Neurovirulence determinants of genetically engineered Theiler viruses.
Proc. Natl. Acad. Sci. USA
87:4125-4129[Abstract/Free Full Text].
|
| 7.
|
Ghadge, G. D.,
L. Ma,
S. Sato,
J. Kim, and P. R. Roos.
1998.
A protein critical for a Theiler's virus-induced immune system-mediated demyelinating disease has a cell type-specific antiapoptotic effect and a key role in virus persistence.
J. Virol.
72:8605-8612[Abstract/Free Full Text].
|
| 8.
|
Kong, W.-P., and R. P. Roos.
1991.
Alternative translation initiation site in the DA strain of Theiler's murine encephalomyelitis virus.
J. Virol.
65:3395-3399[Abstract/Free Full Text].
|
| 9.
|
Lin, X.,
R. P. Roos,
L. R. Pease,
P. Wettstein, and M. Rodriguez.
1999.
A Theiler's virus alternatively initiated protein inhibits the generation of H-2K-restricted virus-specific cytotoxicity.
J. Immunol.
162:17-24[Abstract/Free Full Text].
|
| 10.
|
Lipton, H. L.
1980.
Persistent Theiler's murine encephalomyelitis virus infection in mice depends on plaque size.
J. Gen. Virol.
46:169-177[Abstract/Free Full Text].
|
| 11.
|
Lipton, H. L.,
M. Calenoff,
P. Bandyopadhyay,
S. D. Miller,
M. C. Dal Canto,
S. Gerety, and K. Jensen.
1991.
The 5' noncoding sequences from a less virulent Theiler's virus dramatically attenuate GDVII neurovirulence.
J. Virol.
65:4370-4377[Abstract/Free Full Text].
|
| 12.
|
Lipton, H. L.,
G. Twaddle, and M. L. Jelachich.
1995.
The predominant virus antigen burden is present in macrophages in Theiler's murine encephalomyelitis virus-induced demyelinating disease.
J. Virol.
69:2525-2533[Abstract].
|
| 13.
|
Lorch, Y.,
A. Friedmann,
H. L. Lipton, and M. Kotler.
1981.
Theiler's murine encephalomyelitis virus group includes two distinct genetic subgroups that differ pathologically and biologically.
J. Virol.
40:560-567[Abstract/Free Full Text].
|
| 14.
|
Michiels, T.,
N. Jarousse, and M. Brahic.
1995.
Analysis of the leader and capsid coding regions of persistent and neurovirulent strains of Theiler's virus.
Virology
214:550-558[CrossRef][Medline].
|
| 15.
|
Obuchi, M.,
Y. Ohara,
T. Takegami,
T. Murayama,
H. Takada, and H. Iizuka.
1997.
Theiler's murine encephalomyelitis virus subgroup strain-specific infection in a murine macrophage-like cell line.
J. Virol.
71:729-733[Abstract].
|
| 16.
|
Obuchi, M., and Y. Ohara.
1998.
Theiler's murine encephalomyelitis virus and mechanisms of its persistence.
Neuropathology
18:13-18.
|
| 17.
|
Obuchi, M.,
J. Yamamoto,
M. N. Uddin,
T. Odagiri,
H. Iizuka, and Y. Ohara.
1999.
Theiler's murine encephalomyelitis virus (TMEV) subgroup strain-specific infection in neural and non-neural cell lines.
Microbiol. Immunol.
43:885-892[Medline].
|
| 18.
|
Ohara, Y., and R. Roos.
1987.
The antibody response in Theiler's virus infection: new perspectives on multiple sclerosis.
Prog. Med. Virol.
34:156-179[Medline].
|
| 19.
|
Ohara, Y.,
S. Stein,
J. Fu,
L. Stillman,
L. Klaman, and R. P. Roos.
1988.
Molecular cloning and sequence determination of DA strain of Theiler's murine encephalomyelitis viruses.
Virology
164:245-255[CrossRef][Medline].
|
| 20.
|
Pevear, D. C.,
M. Calenoff,
E. Rozhon, and H. L. Lipton.
1987.
Analysis of the complete nucleotide sequence of the picornavirus Theiler's murine encephalomyelitis virus indicates that it is closely related to cardioviruses.
J. Virol.
61:1507-1516[Abstract/Free Full Text].
|
| 21.
|
Pevear, D. C.,
J. Borkowski,
M. Calenoff,
C. K. Oh,
B. Ostrowski, and H. L. Lipton.
1988.
Insights into Theiler's virus neurovirulence based on a genomic comparison of the neurovirulent GDVII and less virulent BeAn strains.
Virology
165:1-12[CrossRef][Medline].
|
| 22.
|
Ralph, P.,
J. Prichard, and M. Cohn.
1975.
Reticulum cell sarcoma: an effector cell in antibody-dependent cell-mediated immunity.
J. Immunol.
114:898-905[Medline].
|
| 23.
|
Roos, R. P.,
S. Stein,
Y. Ohara,
J. Fu, and B. L. Semler.
1989.
Infectious cDNA clones of the DA strain of Theiler's murine encephalomyelitis virus.
J. Virol.
63:5492-5496[Abstract/Free Full Text].
|
| 24.
|
Rueckert, R. R.
1996.
Picornaviridae: the viruses and their replication, p. 609-654.
In
B. N. Fields, D. M. Knipe, P. M. Howley, R. M. Chanock, J. L. Melnick, T. P. Monath, B. Roizman, and S. E. Straus (ed.), Fields virology, 3rd ed., vol. 1. Lippincott-Raven, Philadelphia, Pa.
|
| 25.
|
Takata, H.,
M. Obuchi,
J. Yamamoto,
T. Odagiri,
R. P. Roos,
H. Iizuka, and Y. Ohara.
1998.
L* protein of the DA strain of Theiler's murine encephalomyelitis virus is important for virus growth in a murine macrophage-like cell line.
J. Virol.
72:4950-4955[Abstract/Free Full Text].
|
Journal of Virology, May 2000, p. 4898-4901, Vol. 74, No. 10
0022-538X/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Asakura, K., Murayama, H., Himeda, T., Ohara, Y.
(2007). Expression of L* protein of Theiler's murine encephalomyelitis virus in the chronic phase of infection. J. Gen. Virol.
88: 2268-2274
[Abstract]
[Full Text]
-
Takano-Maruyama, M., Ohara, Y., Asakura, K., Okuwa, T.
(2006). Theiler's Murine Encephalomyelitis Virus Leader Protein Amino Acid Residue 57 Regulates Subgroup-Specific Virus Growth on BHK-21 Cells. J. Virol.
80: 12025-12031
[Abstract]
[Full Text]
-
Mena, I., Roussarie, J.-P., Brahic, M.
(2004). Infection of Macrophage Primary Cultures by Persistent and Nonpersistent Strains of Theiler's Virus: Role of Capsid and Noncapsid Viral Determinants. J. Virol.
78: 13356-13361
[Abstract]
[Full Text]
-
Oleszak, E. L., Chang, J. R., Friedman, H., Katsetos, C. D., Platsoucas, C. D.
(2004). Theiler's Virus Infection: a Model for Multiple Sclerosis. Clin. Microbiol. Rev.
17: 174-207
[Abstract]
[Full Text]
-
Asakura, K., Murayama, H., Himeda, T., Ohara, Y.
(2002). Epitope-Tagged L* Protein of Theiler's Murine Encephalomyelitis Virus Is Expressed in the Central Nervous System in the Acute Phase of Infection. J. Virol.
76: 13049-13054
[Abstract]
[Full Text]
-
van Eyll, O., Michiels, T.
(2002). Non-AUG-Initiated Internal Translation of the L* Protein of Theiler's Virus and Importance of This Protein for Viral Persistence. J. Virol.
76: 10665-10673
[Abstract]
[Full Text]